Home > Boards > US Listed > Biotechs >

Nkarta Inc (NKTX)

NKTX RSS Feed
Add NKTX Price Alert      Hide Sticky   Hide Intro
Moderator: jondoeuk
Search This Board: 
Last Post: 2/19/2021 1:36:59 PM - Followers: 1 - Board type: Free - Posts Today: 0

NKTX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NKTX News: Nkarta Announces February and March 2021 Investor Conference Schedule 02/17/2021 04:03:00 PM
NKTX News: Amended Statement of Ownership (sc 13g/a) 02/16/2021 04:39:34 PM
NKTX News: Amended Statement of Ownership (sc 13g/a) 02/12/2021 12:37:24 PM
NKTX News: Statement of Ownership (sc 13g) 02/02/2021 03:17:23 PM
NKTX News: Current Report Filing (8-k) 01/19/2021 10:46:48 AM
PostSubject
#24   Preclinical data from another group https://www.frontiersin.org/articles/10.3389 jondoeuk 02/19/21 01:36:59 PM
#23   Going forward, I would like them to insert jondoeuk 02/12/21 07:35:36 PM
#22   Some interesting info from one of the patents jondoeuk 02/12/21 07:31:44 PM
#21   Today, they announced three new exclusive license agreements. jondoeuk 12/17/20 02:50:10 PM
#20   ASH slides https://www.nkartatx.com/file.cfm/75/docs/1040_Nkarta_ASH_2020_NKX101 jondoeuk 12/06/20 04:05:41 PM
#19   (OT) Interesting https://www.sciencedirect.com/science/article/abs/pii/S15250016 jondoeuk 11/26/20 04:08:44 PM
#18   (OT) Catamaran Bio [1] has raised $42M in jondoeuk 11/25/20 02:56:49 PM
#17   SITC poster https://www.nkartatx.com/file.cfm/75/docs/Nkarta_SITC_2020_NKX019_pr jondoeuk 11/10/20 04:31:46 PM
#16   NKX101 trial overview https://ash.confex.com/ash/2020/webprogram/Paper134625.htm jondoeuk 11/04/20 06:55:12 PM
#15   Preclinical from FATE (to be presented at ASH) https://ashpublications.org/blood jondoeuk 11/04/20 06:07:37 PM
#14   (OT) Another interesting product https://www.biorxiv.org/content/10.1101/2020.10 jondoeuk 10/23/20 09:22:08 PM
#13   (OT) ONK Therapeutics jondoeuk 10/23/20 09:07:04 PM
#11   Based on papers, such as these [1,2], and jondoeuk 10/18/20 02:30:49 PM
#10   A CAR-NK cell product targeting MICA/B should overcome jondoeuk 10/15/20 09:25:55 PM
#9   SITC Just one entitled: Preclinical evaluation of NKX019, a jondoeuk 10/14/20 06:23:24 PM
#8   Beyond this the product could be further engineered jondoeuk 10/02/20 08:15:40 PM
#7   For the allo CAR-T product ('personalised' for certain jondoeuk 10/02/20 07:54:12 PM
#6   I hope for the combo CAR-T plus CAR-NK jondoeuk 10/02/20 07:39:43 PM
#5   Jefferies Cell Therapy Virtual Summit https://wsw.com/webcast/jeff146/nktx/18833 jondoeuk 10/02/20 02:22:22 PM
#4   Here is the link https://www.webcaster4.com/Webcast/Page/2495/37211 jondoeuk 09/12/20 02:02:38 PM
#3   At AACR the company showed that an optimised jondoeuk 09/11/20 09:43:45 PM
#2   In this paper the authors at MDA demonstrate jondoeuk 09/11/20 09:42:54 PM
#1   Executive management plans to participate in a fireside jondoeuk 08/31/20 06:22:28 PM
PostSubject
Consent Preferences